It's a
Game Changer.

It's a Game Changer.

One Addition. Every Outcome Multiplied.

0 M

Americans are in chronic pain

0 %+

MLS patients show significant improvement

0 +

Years of MLS Laser research

0

Papers written

Better Business. Better Medicine. Better Life.

Advance your practice with a game-changing technological edge designed to improve outcomes, expand treatment capabilities, and add a powerful new revenue-generating therapy. With no payments for the first year, practices can begin treating patients immediately, keep startup costs low, and add a high-demand therapy to their care model from day one.

Bringing MLS Laser Therapy into your practice is easier than ever.

Practices can begin treating patients immediately while keeping first-year startup costs remarkably low.

$0

down

0 payments

for the first 6 months

$99/month

for the next 6 months

$594 rebate

in month 5—which covers your remaining payments in full†

†Certain conditions apply. Subject to credit approval.

Hear the Results. See the Momentum.

"Every Practice Should Have an MLS Laser"

Regencore pairs orthobiologics with MLS Laser Therapy — and sees patient response rates as high as 90%.

"Universally Tolerated by Every Patient I Have"

A foundational treatment that boosts blood flow, cuts inflammation, and lets the body heal itself — delivered by the laser, not an extra hire.

Hear From Both Practitioners and Patients

Versatile enough to improve outcomes and speed recovery, MLS Laser Therapy has grown into a business of its own — bringing in far more patients along the way.

Download the MLS Laser Therapy Scientific Report.

MLS Laser Therapy is a new treatment for pain, inflammation, edema, and repairing superficial lesions. It was created to overcome the limitations of traditional low-level laser therapy.

MLS Laser Therapy has been developed and tested through rigorous biomedical and clinical research.

This 70-page report discusses:

Find out how MLS can multiply the outcomes for your practice and your patients

in just 20 minutes.